+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Conatus Pharmaceuticals - logo

Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Its lead compound, emricasan, is a first-in-class, orally active pan-caspase protease inhibitor designed to reduce the activity of human caspases. In December 2016, Conatus announced an exclusive option, collaboration and license agreement with Novartis for the global development and commercialization of emricasan. The company was founded in 2005 and is headquartered in San Diego, California.

From
From
From
From
Colorectal Cancer - Pipeline Review, H2 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H2 2018

  • Drug Pipelines
  • December 2018
  • 2548 Pages
From
Colorectal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • June 2018
  • 2237 Pages
From
From
From
From
From
From
Portal Hypertension - Pipeline Insight, 2020 - Product Thumbnail Image

Portal Hypertension - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Caspases Activators -Pipeline Insight, 2019 - Product Thumbnail Image

Caspases Activators -Pipeline Insight, 2019

  • Drug Pipelines
  • January 2019
  • 60 Pages
From
Portal Hypertension- Pipeline Insights, 2019 - Product Thumbnail Image

Portal Hypertension- Pipeline Insights, 2019

  • Drug Pipelines
  • August 2018
From
From
Loading Indicator
adroll